[Staphylococcus nasal carriage and infection of central venous ports in oncology].
ANNALES FRANCAISES D'ANESTHESIE ET DE REANIMATION 2000;
19:93-5. [PMID:
10730170 DOI:
10.1016/s0750-7658(00)00115-5]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
OBJECTIVE
To assess the risk of infection of either subcutaneously implanted central venous access devices or percutaneous central venous catheters inserted via a subcutaneous tunnel in cancer patients with a positive staphylococcal nasal carriage.
STUDY DESIGN
Prospective study.
PATIENTS
The study included 266 patients undergoing cancer chemotherapy.
METHOD
A nasal swab was taken prior to insertion of the venous access device and the patients were followed over 30 days for the occurrence of a staphylococcal infection (hemoculture and device or site of insertion).
RESULTS
A nasal staphylococcal nasal carriage was found in 227 patients. Out of the 15 developing a device infection, a staphylococcal nasal colonization was existing in nine patients. Bacteriological screening a sensitivity of 60% and a specificity of 13%.
CONCLUSION
Bacteriological screening at the time of device insertion of a central venous access device is of no value for the detection of patients at risk of staphylococcal infection of the device.
Collapse